Allocating to Capacity, Not Just Sharpe
The best-looking Sharpe ratio can be a trap if the strategy can only absorb a small amount of capital — a platform allocating purely on Sharpe will overfund tiny strategies and starve the ones that can actually move the needle.
Prerequisites: Multi-Strategy Capital Allocation
Sharpe ratio measures return per unit of risk, and it is the single number most allocators reach for first. But Sharpe says nothing about how much money a strategy can actually run before it stops working. A strategy trading illiquid microcap stocks might post a stunning Sharpe of 3.0 on a $10 million book — and fall apart entirely if pushed to $200 million, because its own trading would move the very prices it depends on.
Capacity is the amount of capital a strategy can absorb before trading costs, price impact, and crowding erode its edge. Allocating purely on Sharpe ratio, without asking about capacity, systematically misallocates capital on a multi-strategy platform.
A strategy's Sharpe ratio describes its risk-adjusted return at the capital it has already been tested at — it does not tell you what happens if you give the strategy ten times more money. Capacity is the separate, and often more important, question of how much capital a strategy can hold before its own trading erodes the edge it is trying to capture.
Why Sharpe-only allocation goes wrong
Picture a platform with two strategies. Strategy A, trading small-cap stocks, has a Sharpe of 3.0 but can only run $20 million before its own orders start moving prices against it. Strategy B, trading large-cap futures, has a Sharpe of 1.2 but can comfortably run $500 million. A pure Sharpe-ranking allocator would try to overweight Strategy A — but there is nowhere for that extra capital to go without destroying the very edge that produced the 3.0 Sharpe in the first place. Forced past its capacity, Strategy A's realized Sharpe collapses toward Strategy B's, or worse.
Worked example
A platform has $300 million to deploy across the two strategies above. Ranking by Sharpe alone would push as much as possible into Strategy A. But Strategy A's estimated capacity, based on its trading in the underlying stocks' average daily volume, is $20 million; beyond that, transaction costs from price impact are estimated to add roughly 2% of drag per year for every additional $50 million pushed in, enough to erase the Sharpe advantage. A capacity-aware allocation caps Strategy A near $20 million and routes the remaining $280 million to Strategy B, even though Strategy B's Sharpe is lower — the total portfolio's realized, capacity-adjusted return ends up higher than a naive Sharpe-ranked split would have delivered.
What this means in practice
Sophisticated multi-strategy allocators build a capacity estimate for every strategy alongside its Sharpe, usually derived from how large its typical trades are relative to the market's available liquidity, and size allocations against whichever constraint binds first. A capacity-aware framework will happily fund a mediocre-Sharpe strategy at scale over a spectacular one that cannot absorb meaningful capital, because total dollars of risk-adjusted profit — not the ratio itself — is what actually shows up in the fund's P&L.
When comparing two strategies' Sharpe ratios, always ask "Sharpe at what size?" — a Sharpe ratio quietly reported at a strategy's current, possibly tiny, capital base tells you much less than the same number reported alongside its estimated capacity.
Related concepts
Practice in interviews
Further reading
- Grinold and Kahn, Active Portfolio Management (ch. on capacity and transaction costs)